Global (United States, European Union and China) Cancer Biomarker Market Research Report 2019-2025

SKU ID :QYR-13828932 | Published Date: 23-Aug-2019 | No. of pages: 121
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Cancer Biomarker Market Size Growth Rate by Type (2019-2025) 1.3.2 Protein Biomarker 1.3.3 Genetic Biomarker 1.4 Market Segment by Application 1.4.1 Global Cancer Biomarker Market Share by Application (2019-2025) 1.4.2 Diagnostics 1.4.3 Research 1.4.4 Prognostics 1.4.5 Risk Assessment 1.4.6 Other Applications 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Cancer Biomarker Market Size 2.1.1 Global Cancer Biomarker Revenue 2014-2025 2.1.2 Global Cancer Biomarker Sales 2014-2025 2.2 Cancer Biomarker Growth Rate by Regions 2.2.1 Global Cancer Biomarker Sales by Regions 2014-2019 2.2.2 Global Cancer Biomarker Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Cancer Biomarker Sales by Manufacturers 3.1.1 Cancer Biomarker Sales by Manufacturers 2014-2019 3.1.2 Cancer Biomarker Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Cancer Biomarker Revenue by Manufacturers (2014-2019) 3.2.2 Cancer Biomarker Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Cancer Biomarker Market Concentration Ratio (CR5 and HHI) 3.3 Cancer Biomarker Price by Manufacturers 3.4 Key Manufacturers Cancer Biomarker Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Cancer Biomarker Market 3.6 Key Manufacturers Cancer Biomarker Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Protein Biomarker Sales and Revenue (2014-2019) 4.1.2 Genetic Biomarker Sales and Revenue (2014-2019) 4.2 Global Cancer Biomarker Sales Market Share by Type 4.3 Global Cancer Biomarker Revenue Market Share by Type 4.4 Cancer Biomarker Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Cancer Biomarker Sales by Application 6 United States 6.1 United States Cancer Biomarker Breakdown Data by Company 6.2 United States Cancer Biomarker Breakdown Data by Type 6.3 United States Cancer Biomarker Breakdown Data by Application 7 European Union 7.1 European Union Cancer Biomarker Breakdown Data by Company 7.2 European Union Cancer Biomarker Breakdown Data by Type 7.3 European Union Cancer Biomarker Breakdown Data by Application 8 China 8.1 China Cancer Biomarker Breakdown Data by Company 8.2 China Cancer Biomarker Breakdown Data by Type 8.3 China Cancer Biomarker Breakdown Data by Application 9 Rest of World 9.1 Rest of World Cancer Biomarker Breakdown Data by Company 9.2 Rest of World Cancer Biomarker Breakdown Data by Type 9.3 Rest of World Cancer Biomarker Breakdown Data by Application 9.4 Rest of World Cancer Biomarker Breakdown Data by Countries 9.4.1 Rest of World Cancer Biomarker Sales by Countries 9.4.2 Rest of World Cancer Biomarker Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Thermo Fisher Scientific 10.1.1 Thermo Fisher Scientific Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Cancer Biomarker 10.1.4 Cancer Biomarker Product Introduction 10.1.5 Thermo Fisher Scientific Recent Development 10.2 Bio-Rad Laboratories 10.2.1 Bio-Rad Laboratories Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Cancer Biomarker 10.2.4 Cancer Biomarker Product Introduction 10.2.5 Bio-Rad Laboratories Recent Development 10.3 Roche Diagnostics 10.3.1 Roche Diagnostics Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Cancer Biomarker 10.3.4 Cancer Biomarker Product Introduction 10.3.5 Roche Diagnostics Recent Development 10.4 Qiagen 10.4.1 Qiagen Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Cancer Biomarker 10.4.4 Cancer Biomarker Product Introduction 10.4.5 Qiagen Recent Development 10.5 Illumina 10.5.1 Illumina Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Cancer Biomarker 10.5.4 Cancer Biomarker Product Introduction 10.5.5 Illumina Recent Development 10.6 GE Healthcare 10.6.1 GE Healthcare Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Cancer Biomarker 10.6.4 Cancer Biomarker Product Introduction 10.6.5 GE Healthcare Recent Development 10.7 Agilent Technologies 10.7.1 Agilent Technologies Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Cancer Biomarker 10.7.4 Cancer Biomarker Product Introduction 10.7.5 Agilent Technologies Recent Development 10.8 Biomérieux SA 10.8.1 Biomérieux SA Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Cancer Biomarker 10.8.4 Cancer Biomarker Product Introduction 10.8.5 Biomérieux SA Recent Development 10.9 Merck & Co. 10.9.1 Merck & Co. Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Cancer Biomarker 10.9.4 Cancer Biomarker Product Introduction 10.9.5 Merck & Co. Recent Development 10.10 Abbott Laboratories 10.10.1 Abbott Laboratories Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Cancer Biomarker 10.10.4 Cancer Biomarker Product Introduction 10.10.5 Abbott Laboratories Recent Development 10.11 Becton, Dickinson and Company 10.12 Danaher Corporation 10.13 Myriad Genetics 10.14 Sysmex Corporation 10.15 Hologic 10.16 Quest Diagnostics 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Cancer Biomarker Sales Channels 11.2.2 Cancer Biomarker Distributors 11.3 Cancer Biomarker Customers 12 Market Forecast 12.1 Global Cancer Biomarker Sales and Revenue Forecast 2019-2025 12.2 Global Cancer Biomarker Sales Forecast by Type 12.3 Global Cancer Biomarker Sales Forecast by Application 12.4 Cancer Biomarker Forecast by Regions 12.4.1 Global Cancer Biomarker Sales Forecast by Regions 2019-2025 12.4.2 Global Cancer Biomarker Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
List of Tables and Figures Figure Cancer Biomarker Product Picture Table Cancer Biomarker Key Market Segments Table Major Manufacturers Cancer Biomarker Covered in This Report Table Global Cancer Biomarker Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Cancer Biomarker Sales Market Shar by Type 2014-2025 Figure Protein Biomarker Figures Table Major Manufacturers of Protein Biomarker Figure Genetic Biomarker Figures Table Major Manufacturers of Genetic Biomarker Table Global Cancer Biomarker Market Share by Application 2019-2025 (K Units) Figure Diagnostics Use Case Figure Research Use Case Figure Prognostics Use Case Figure Risk Assessment Use Case Figure Other Applications Use Case Figure Cancer Biomarker Report Years Considered Figure Global Cancer Biomarker Market Size 2014-2025 (Million US$) Figure Global Cancer Biomarker Sales 2014-2019 (K Units) Table Global Cancer Biomarker Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Cancer Biomarker Sales by Regions 2014-2019 (K Units) Table Global Cancer Biomarker Sales Market Share by Regions 2014-2019 Figure Global Cancer Biomarker Sales Market Share by Regions 2014-2019 Figure Global Cancer Biomarker Sales Market Share by Regions in 2019 Table Global Cancer Biomarker Revenue by Regions 2014-2019 (Million US$) Table Global Cancer Biomarker Revenue Market Share by Regions 2014-2019 Figure Global Cancer Biomarker Revenue Market Share by Regions 2014-2019 Figure Global Cancer Biomarker Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Cancer Biomarker Sales by Manufacturers (2014-2019) (K Units) Table Global Cancer Biomarker Sales Share by Manufacturers (2014-2019) Figure Global Cancer Biomarker Sales Share by Manufacturers in 2019 Table Cancer Biomarker Revenue by Manufacturers (2014-2019) (Million USD) Table Cancer Biomarker Revenue Share by Manufacturers (2014-2019) Figure Cancer Biomarker Value Share by Manufacturers in 2019 Table Global Cancer Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Cancer Biomarker Price (2014-2019) (USD/Unit) Table Key Manufacturers Cancer Biomarker Plants/Factories Distribution Table Key Manufacturers Cancer Biomarker Area Served Table Date of Key Manufacturers Enter into Cancer Biomarker Market Table Key Manufacturers Cancer Biomarker Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Protein Biomarker Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Genetic Biomarker Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Cancer Biomarker Sales by Type (2014-2019) (K Units) Table Global Cancer Biomarker Sales Share by Type (2014-2019) Figure Global Cancer Biomarker Sales Market Share by Type (2014-2019) Figure Global Cancer Biomarker Sales Market Share by Type in 2018 Table Global Cancer Biomarker Revenue by Type (2014-2019) (Million US$) Table Global Cancer Biomarker Revenue Share by Type (2014-2019) Figure Global Cancer Biomarker Revenue Market Share by Type (2014-2019) Figure Global Cancer Biomarker Revenue Market Share by Type in 2018 Table Cancer Biomarker Price by Type 2014-2019 (USD/Unit) Table Global Cancer Biomarker Sales by Application (2014-2019) (K Units) Table Global Cancer Biomarker Sales Share by Application (2014-2019) Figure Global Sales Cancer Biomarker Market Share by Application (2014-2019) Figure Global Sales Cancer Biomarker Market Share by Application (2014-2019) Figure United States Cancer Biomarker Sales Growth Rate 2014-2019 (K Units) Figure United States Cancer Biomarker Revenue Growth Rate 2014-2019 (Million US$) Table United States Cancer Biomarker Sales by Company (2014-2019) (K Units) Table United States Cancer Biomarker Sales Market Share by Company (2014-2019) Figure United States Cancer Biomarker Sales Market Share by Company in 2019 Table United States Cancer Biomarker Sales by Type (2014-2019) (K Units) Table United States Cancer Biomarker Sales Market Share by Type (2014-2019) Figure United States Cancer Biomarker Market Share by Type in 2019 Table United States Cancer Biomarker Sales by Application (2014-2019) (K Units) Table United States Cancer Biomarker Sales Market Share by Application (2014-2019) Figure United States Cancer Biomarker Market Share by Application in 2019 Figure European Union Cancer Biomarker Sales Growth Rate 2014-2019 (K Units) Figure European Union Cancer Biomarker Revenue Growth Rate 2014-2019 (Million US$) Table European Union Cancer Biomarker Sales by Company (2014-2019) (K Units) Table European Union Cancer Biomarker Sales Market Share by Company (2014-2019) Figure European Union Cancer Biomarker Sales Market Share by Company in 2019 Table European Union Cancer Biomarker Sales by Type (2014-2019) (K Units) Table European Union Cancer Biomarker Sales Market Share by Type (2014-2019) Figure 2018 European Union Cancer Biomarker Market Share by Type Table European Union Cancer Biomarker Sales by Application (2014-2019) (K Units) Table European Union Cancer Biomarker Sales Market Share by Application (2014-2019) Figure 2018 European Union Cancer Biomarker Market Share by Application Figure China Cancer Biomarker Sales Growth Rate 2014-2019 (K Units) Figure China Cancer Biomarker Revenue Growth Rate 2014-2019 (Million US$) Table China Cancer Biomarker Sales by Company (2014-2019) (K Units) Table China Cancer Biomarker Sales Market Share by Company (2014-2019) Figure China Cancer Biomarker Sales Market Share by Company in 2019 Table China Cancer Biomarker Sales by Type (2014-2019) (K Units) Table China Cancer Biomarker Sales Market Share by Type (2014-2019) Figure China Cancer Biomarker Market Share by Type in 2019 Table China Cancer Biomarker Sales by Application (2014-2019) (K Units) Table China Cancer Biomarker Sales Market Share by Application (2014-2019) Figure China Cancer Biomarker Market Share by Application in 2019 Figure Rest of World Cancer Biomarker Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Cancer Biomarker Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Cancer Biomarker Sales by Company (2014-2019) (K Units) Table Rest of World Cancer Biomarker Sales Market Share by Company (2014-2019) Figure Rest of World Cancer Biomarker Sales Market Share by Company in 2019 Table Rest of World Cancer Biomarker Sales by Type (2014-2019) (K Units) Table Rest of World Cancer Biomarker Sales Market Share by Type (2014-2019) Figure Rest of World Cancer Biomarker Market Share by Type in 2019 Table Rest of World Cancer Biomarker Sales by Application (2014-2019) (K Units) Table Rest of World Cancer Biomarker Sales Market Share by Application (2014-2019) Figure Rest of World Cancer Biomarker Market Share by Application in 2019 Table Rest of World Cancer Biomarker Sales by Countries (2014-2019) (K Units) Table Rest of World Cancer Biomarker Sales Market Share by Countries (2014-2019) Figure Rest of World Cancer Biomarker Sales Market Share by Countries in 2019 Table Rest of World Cancer Biomarker Revenue by Countries (2014-2019) (Million US$) Table Rest of World Cancer Biomarker Revenue Market Share by Countries (2014-2019) Figure Rest of World Cancer Biomarker Revenue Market Share by Countries in 2019 Figure Japan Cancer Biomarker Sales Growth Rate (2014-2019) (K Units) Figure Japan Cancer Biomarker Revenue Growth Rate (2014-2019) (K Units) Figure Korea Cancer Biomarker Sales Growth Rate (2014-2019) (K Units) Figure Korea Cancer Biomarker Revenue Growth Rate (2014-2019) (K Units) Figure India Cancer Biomarker Sales Growth Rate (2014-2019) (K Units) Figure India Cancer Biomarker Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Cancer Biomarker Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Cancer Biomarker Revenue Growth Rate (2014-2019) (K Units) Table Thermo Fisher Scientific Company Details Table Thermo Fisher Scientific Description and Business Overview Table Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Thermo Fisher Scientific Cancer Biomarker Sales Growth Rate (2014-2019) Table Thermo Fisher Scientific Cancer Biomarker Sales Market Share in Global Market Table Thermo Fisher Scientific Recent Development Table Bio-Rad Laboratories Company Details Table Bio-Rad Laboratories Description and Business Overview Table Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Bio-Rad Laboratories Cancer Biomarker Sales Growth Rate (2014-2019) Table Bio-Rad Laboratories Cancer Biomarker Sales Market Share in Global Market Table Bio-Rad Laboratories Recent Development Table Roche Diagnostics Company Details Table Roche Diagnostics Description and Business Overview Table Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Diagnostics Cancer Biomarker Sales Growth Rate (2014-2019) Table Roche Diagnostics Cancer Biomarker Sales Market Share in Global Market Table Roche Diagnostics Recent Development Table Qiagen Company Details Table Qiagen Description and Business Overview Table Qiagen Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Qiagen Cancer Biomarker Sales Growth Rate (2014-2019) Table Qiagen Cancer Biomarker Sales Market Share in Global Market Table Qiagen Recent Development Table Illumina Company Details Table Illumina Description and Business Overview Table Illumina Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Illumina Cancer Biomarker Sales Growth Rate (2014-2019) Table Illumina Cancer Biomarker Sales Market Share in Global Market Table Illumina Recent Development Table GE Healthcare Company Details Table GE Healthcare Description and Business Overview Table GE Healthcare Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table GE Healthcare Cancer Biomarker Sales Growth Rate (2014-2019) Table GE Healthcare Cancer Biomarker Sales Market Share in Global Market Table GE Healthcare Recent Development Table Agilent Technologies Company Details Table Agilent Technologies Description and Business Overview Table Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Agilent Technologies Cancer Biomarker Sales Growth Rate (2014-2019) Table Agilent Technologies Cancer Biomarker Sales Market Share in Global Market Table Agilent Technologies Recent Development Table Biomérieux SA Company Details Table Biomérieux SA Description and Business Overview Table Biomérieux SA Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Biomérieux SA Cancer Biomarker Sales Growth Rate (2014-2019) Table Biomérieux SA Cancer Biomarker Sales Market Share in Global Market Table Biomérieux SA Recent Development Table Merck & Co. Company Details Table Merck & Co. Description and Business Overview Table Merck & Co. Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck & Co. Cancer Biomarker Sales Growth Rate (2014-2019) Table Merck & Co. Cancer Biomarker Sales Market Share in Global Market Table Merck & Co. Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Description and Business Overview Table Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Laboratories Cancer Biomarker Sales Growth Rate (2014-2019) Table Abbott Laboratories Cancer Biomarker Sales Market Share in Global Market Table Abbott Laboratories Recent Development Table Becton, Dickinson and Company Company Details Table Danaher Corporation Company Details Table Myriad Genetics Company Details Table Sysmex Corporation Company Details Table Hologic Company Details Table Quest Diagnostics Company Details Figure Cancer Biomarker Value Chain Table Cancer Biomarker Distributors List Table Cancer Biomarker Customers List Table Global Cancer Biomarker Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure Global Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Table Global Cancer Biomarker Sales Forecast by Type 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Forecast by Type 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Market Share Forecast by Type 2019-2025 Table Global Cancer Biomarker Sales Forecast by Application 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Forecast by Application 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Market Share Forecast by Application 2019-2025 Table Global Cancer Biomarker Sales Forecast by Regions 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Forecast by Regions 2019-2025 (K Units) Figure Global Cancer Biomarker Sales Market Share Forecast by Regions 2019-2025 Table Global Cancer Biomarker Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Cancer Biomarker Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Cancer Biomarker Revenue Market Share Forecast by Regions 2019-2025 Figure United States Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure United States Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure European Union Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure European Union Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure China Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure China Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure Japan Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure Japan Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure Korea Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure Korea Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure India Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure India Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Cancer Biomarker Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Cancer Biomarker Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Thermo Fisher Scientific Bio-Rad Laboratories Roche Diagnostics Qiagen Illumina GE Healthcare Agilent Technologies Biomérieux SA Merck & Co. Abbott Laboratories Becton, Dickinson and Company Danaher Corporation Myriad Genetics Sysmex Corporation Hologic Quest Diagnostics
  • PRICE
  • $3280
    $6560

Our Clients